Cynosure Inc (CYNO) Financial Statements (2025 and earlier)

Company Profile

Business Address 5 CARLISLE ROAD
WESTFORD, MA 01886
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments172,097170,412139,933143,999119,834122,800
Cash and cash equivalent130,997126,27693,464108,58781,40593,073
Short-term investments41,10044,13646,46935,41238,42929,727
Receivables40,82740,59138,51742,01244,93347,658
Inventory, net of allowances, customer advances and progress billings83,92683,56785,64879,76874,31073,352
Inventory83,92683,56785,64879,76874,31073,352
Other undisclosed current assets29,74122,88316,08421,35632,02230,836
Total current assets:326,591317,453280,182287,135271,099274,646
Noncurrent Assets
Property, plant and equipment45,85845,28543,22039,70638,46135,348
Long-term investments and receivables42,16739,88238,22638,76133,42022,405
Long-term investments42,16739,88238,22638,76133,42022,405
Intangible assets, net (including goodwill)143,724145,842148,003150,124152,462154,831
Goodwill105,865105,833105,845105,807105,794105,860
Intangible assets, net (excluding goodwill)37,85940,00942,15844,31746,66848,971
Other noncurrent assets1,0571,0841,0251,0022,3252,340
Deferred tax assets, net14,66415,77818,26117,882  
Total noncurrent assets:247,470247,871248,735247,475226,668214,924
TOTAL ASSETS:574,061565,324528,917534,610497,767489,570
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities76,18472,59767,50579,50162,82065,184
Accounts payable26,40629,65825,93133,88522,11426,651
Accrued liabilities49,77842,93941,57445,61640,70638,533
Debt958960904741525324
Deferred revenue and credits21,27826,47324,01224,80316,14012,121
Total current liabilities:98,420100,03092,421105,04579,48577,629
Noncurrent Liabilities
Long-term debt and lease obligation16,97417,14517,36917,37217,06816,763
Capital lease obligations16,97417,14517,36917,37217,06816,763
Liabilities, other than long-term debt7,4537,8477,4987,79111,34211,484
Deferred revenue and credits1,0991,343991903847815
Other liabilities6,3546,5046,5076,88810,49510,669
Total noncurrent liabilities:24,42724,99224,86725,16328,41028,247
Total liabilities:122,847125,022117,288130,208107,895105,876
Equity
Equity, attributable to parent451,214440,302411,629404,402389,872383,694
Common stock252524242424
Treasury stock, value(33,104)(33,104)(33,104)(33,104)(33,104)(33,104)
Additional paid in capital420,225413,422390,770387,161379,824376,396
Accumulated other comprehensive loss(5,063)(5,009)(4,689)(5,460)(5,425)(4,946)
Retained earnings69,13164,96858,62855,78148,55345,324
Total equity:451,214440,302411,629404,402389,872383,694
TOTAL LIABILITIES AND EQUITY:574,061565,324528,917534,610497,767489,570

Income Statement (P&L) ($ in thousands)

12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
Revenues106,386110,34394,664102,44278,41483,694
Cost of revenue(43,576)(45,286)(39,244)(43,442)(34,009)(36,338)
Gross profit:62,81065,05755,42059,00044,40547,356
Operating expenses(54,648)(54,557)(50,969)(47,208)(39,570)(39,715)
Operating income:8,16210,5004,45111,7924,8357,641
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
245(277)660(45)(216)484
Interest and debt expense  (469)(456)  
Income from continuing operations before equity method investments, income taxes:8,40710,2234,64211,2914,6198,125
Other undisclosed income (loss) from continuing operations before income taxes(377)(392)5733(428)(430)
Income from continuing operations before income taxes:8,0309,8314,69911,3244,1917,695
Income tax expense(3,867)(3,491)(1,852)(4,096)(962)(2,337)
Income from continuing operations:4,1636,3402,8477,2283,2295,358
Income before gain (loss) on sale of properties:4,1636,3402,8477,2283,2295,358
Net income available to common stockholders, diluted:4,1636,3402,8477,2283,2295,358

Comprehensive Income ($ in thousands)

12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
Net income:4,1636,3402,8477,2283,2295,358
Comprehensive income:4,1636,3402,8477,2283,2295,358
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(54)(320)771(35)(479)283
Comprehensive income (loss), net of tax, attributable to parent:4,1096,0203,6187,1932,7505,641

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: